Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6790
Gene Symbol: AURKA
AURKA 		0.020 GeneticVariation group BEFREE <b>Objective:</b> The objective of this study was aimed to investigate the interactions between Aurora kinase A (<i>AURKA</i>) gene polymorphisms (T91A and G169A) and smoking and their effects on the susceptibility of oral cancer. 31174434 2019
Entrez Id: 9021
Gene Symbol: SOCS3
SOCS3 		0.010 Biomarker group BEFREE <i>Cis-3-O-p-</i>hydroxycinnamoyl Ursolic Acid Induced ROS-Dependent p53-Mediated Mitochondrial Apoptosis in Oral Cancer Cells. 30261716 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.020 Biomarker group BEFREE <sup>18</sup>F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer. 31606761 2020
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.400 Biomarker group BEFREE 91.1% of the oropharynx cancer patients had p16 positive tumors compared to 3.3% of oral cavity cancer. 29312616 2017
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10 		0.080 Biomarker group BEFREE 91.1% of the oropharynx cancer patients had p16 positive tumors compared to 3.3% of oral cavity cancer. 29312616 2017
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.050 AlteredExpression group BEFREE Oral cancer progression and c-erbB-2/neu proto-oncogene expression. 1355405 1992
Entrez Id: 6696
Gene Symbol: SPP1
SPP1 		0.020 Biomarker group BEFREE Oral cancer is prevalent worldwide.Studies have indicated that an increase in the osteopontin (OPN) plasma level is correlated with the progression of oral cancer. 22011514 2012
Entrez Id: 11321
Gene Symbol: GPN1
GPN1 		0.410 GeneticVariation group BEFREE Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 100048912
Gene Symbol: CDKN2B-AS1
CDKN2B-AS1 		0.420 GeneticVariation group BEFREE Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 10319
Gene Symbol: LAMC3
LAMC3 		0.410 GeneticVariation group BEFREE Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 81037
Gene Symbol: CLPTM1L
CLPTM1L 		0.410 GeneticVariation group BEFREE Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 11321
Gene Symbol: GPN1
GPN1 		0.410 GeneticVariation group GWASCAT Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 11321
Gene Symbol: GPN1
GPN1 		0.410 Biomarker group CTD_human Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 10319
Gene Symbol: LAMC3
LAMC3 		0.410 Biomarker group CTD_human Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 10319
Gene Symbol: LAMC3
LAMC3 		0.410 GeneticVariation group GWASCAT Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 100048912
Gene Symbol: CDKN2B-AS1
CDKN2B-AS1 		0.420 GeneticVariation group GWASCAT Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 100048912
Gene Symbol: CDKN2B-AS1
CDKN2B-AS1 		0.420 Biomarker group CTD_human Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 81037
Gene Symbol: CLPTM1L
CLPTM1L 		0.410 GeneticVariation group GWASCAT Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 81037
Gene Symbol: CLPTM1L
CLPTM1L 		0.410 Biomarker group CTD_human Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). 27749845 2016
Entrez Id: 25859
Gene Symbol: PART1
PART1 		0.010 Biomarker group BEFREE Oral Cancer Treatment Through the Ages: Part 1. 30794812 2019
Entrez Id: 9610
Gene Symbol: RIN1
RIN1 		0.010 Biomarker group BEFREE RIN1 appears to be a valuable probe for investigating the process of gene amplification in general and, specifically, 11q13 amplification in oral cancer. 10825000 2000
Entrez Id: 2944
Gene Symbol: GSTM1
GSTM1 		0.100 GeneticVariation group BEFREE GSTM1 null deletion was observed in 49% of oral cancer cases and 33% of control subjects. 11564581 2001
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2 		0.400 AlteredExpression group BEFREE COX-2 expression was correlated to DNA content as a genetic risk marker of oral cancer. 12747975 2003
Entrez Id: 4513
Gene Symbol: COX2
COX2 		0.090 AlteredExpression group BEFREE COX-2 expression was correlated to DNA content as a genetic risk marker of oral cancer. 12747975 2003
Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12 		0.080 AlteredExpression group BEFREE COX-2 expression was correlated to DNA content as a genetic risk marker of oral cancer. 12747975 2003